[
    {
        "institution_name": "MD Anderson Cancer Center||University of Texas in Houston",
        "institution_type": "university-affiliated",
        "parent_organization": "University of Texas",
        "leadership": "Harrys A. Torres, MD",
        "institution_country": "USA",
        "institution_city": "Houston",
        "research_diseases": "Hepatitis C",
        "research_fields": "clinical_research||oncology||virology",
        "key_technologies": "serologic assay||molecular assay",
        "key_achievements": "first prospective study comparing different methods for hepatitis C screening in cancer patients",
        "international_collaboration": "NCI cancer centers in the United States||cancer centers in France||cancer centers in Canada||cancer centers in Italy",
        "funding_sources": "industry grant||government grant",
        "technology_application": "hepatitis C screening in cancer patients"
    },
    {
        "institution_name": "The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research || Guy's & St Thomas' NHS Foundation Trust || Breast Cancer Now Research Unit, Guy's Hospital, King's College London || Translational Cancer Research Unit (TCRU), GZA Ziekenhuizen || GZA Hospital Sint-Augustinus || The Royal Marsden NHS Foundation Trust",
        "institution_type": "university-affiliated || public",
        "parent_organization": "The Institute of Cancer Research || King's College London",
        "leadership": "Clare M. Isacke || A.N. Tutt",
        "institution_country": "United Kingdom || Belgium",
        "institution_city": "London || Antwerp",
        "research_diseases": "breast cancer leptomeningeal metastasis",
        "research_fields": "oncology || clinical_research || genomics",
        "key_technologies": "ultra-low-pass whole genome sequencing (ulpWGS) || droplet digital PCR (ddPCR)",
        "key_achievements": "proof-of-concept for ulpWGS-assessed CSF ctDNA monitoring in BCLM as a potential biomarker to improve current diagnostics and evaluation of treatment response and failure",
        "international_collaboration": "collaboration between The Institute of Cancer Research, King's College London, Guy's & St Thomas' NHS Foundation Trust, GZA Ziekenhuizen, GZA Hospital Sint-Augustinus, The Royal Marsden NHS Foundation Trust",
        "funding_sources": "government grant || philanthropy || international grant",
        "technology_application": "CSF ctDNA measurement for diagnosis and therapeutic monitoring in breast cancer leptomeningeal metastasis"
    },
    {
        "institution_name": "Emory University sleep research team||Emory University||University of Wisconsin",
        "institution_type": "university-affiliated",
        "parent_organization": "Emory University||University of Wisconsin",
        "leadership": "David Rye||Lynn Marie Trotti||Andy Jenkins||David Plante",
        "institution_country": "USA",
        "institution_city": "Atlanta||Madison",
        "research_diseases": "idiopathic hypersomnia||Narcolepsy Type 2||Kleine-Levin-Syndrome||myotonic dystrophy",
        "research_fields": "neuroscience||clinical_research||biochemistry||genomics||pharmacology",
        "key_technologies": "MSLT||EEG||FDG-PET||fMRI||Diffusion Tensor Imaging||proteomics||metabolomics||genetic analysis",
        "key_achievements": "development of Hypersomnia Severity Index||collection of large biorepository of samples",
        "international_collaboration": "Emory University sleep research team and collaborators",
        "funding_sources": "government grant||philanthropy",
        "technology_application": "clinical trials of Pentylenetetrazol (PTZ)||use of flumazenil in treatment-resistant hypersomnia"
    },
    {
        "institution_name": "University of Colorado Cancer Center||Rocky Mountain Cancer Center",
        "institution_type": "university-affiliated||private",
        "parent_organization": "University of Colorado School of Medicine",
        "leadership": "Paul Bunn, MD||Robert Jotte, MD, PhD",
        "institution_country": "USA",
        "institution_city": "Denver",
        "research_diseases": "Advanced Non-Small Cell Lung Cancer (NSCLC)",
        "research_fields": "oncology||clinical_research",
        "key_technologies": "biomarker tumor testing||HDAC inhibitors||EGFR inhibitors||combination therapy (entinostat and erlotinib)",
        "key_achievements": "identification of E-cadherin as a targetable cancer marker||improved survival in NSCLC patients with high E-cadherin expression",
        "international_collaboration": "Syndax Pharmaceuticals",
        "funding_sources": "government grant||industry grant",
        "technology_application": "combination therapy for NSCLC patients with elevated E-cadherin"
    },
    {
        "institution_name": "University of Kansas Cancer Center",
        "institution_type": "public||university-affiliated",
        "parent_organization": "University of Kansas",
        "leadership": "Abdulraheem Yacoub, MD||Roy Jensen, MD",
        "institution_country": "USA",
        "institution_city": "Kansas City",
        "research_diseases": "essential thrombocytosis||polycythemia vera||primary myelofibrosis||chronic myeloid leukemia||systemic mastocytosis||myeloproliferative neoplasms",
        "research_fields": "oncology||clinical_research",
        "key_technologies": "clinical trials||stem cell transplant",
        "key_achievements": "founding member of MPN Research Consortium||clinical trial options for every patient",
        "international_collaboration": "MPN Research Consortium",
        "funding_sources": "government grant",
        "technology_application": "clinical trial participation for MPN patients||stem cell transplant for curative therapy"
    },
    {
        "institution_name": "Cardiovascular Centre of the University of Lisbon (CCUL)||Lisbon School of Medicine, Universidade de Lisboa||Santa Maria University Hospital _ CHULN EPE||Nuclear Medicine Institute of Lisbon School of Medicine||Centro Hospitalar Universitário Lisboa Norte",
        "institution_type": "university-affiliated",
        "parent_organization": "Universidade de Lisboa",
        "leadership": "Azevedo Coutinho, Conceição, MD PhD||Cantinho, Guilhermina, MD||Conceição, Isabel, MD",
        "institution_country": "Portugal",
        "institution_city": "Lisbon",
        "research_diseases": "Familial Amyloid Polyneuropathy (FAP)||cardiac TTR amyloidosis||Transthyretin V30M (TTR-V30M) amyloidosis",
        "research_fields": "clinical_research||medical_imaging||neuroscience",
        "key_technologies": "99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) scintigraphy||cardiac ultrasound tests (2D, M Mode, Doppler, Tissue Doppler, Strain and Strain Rate Imaging, Speckle tracking, 4D)||Nuclear Cardiology",
        "key_achievements": "Largest cohort data on TTR-V30M amyloidosis||Best Cardiology Work award competitor||International award of the American Society of Nuclear Cardiology Congress",
        "international_collaboration": "Columbia University College of Physicians and Surgeons||Columbia Presbyterian Medical Center",
        "funding_sources": "philanthropy",
        "technology_application": "early diagnosis of cardiac TTR amyloidosis using DPD scintigraphy"
    },
    {
        "institution_name": "Center on Mindfulness and Integrative Health Intervention Development",
        "institution_type": "university-affiliated",
        "parent_organization": "University of Utah",
        "leadership": "Eric Garland",
        "institution_country": "USA",
        "institution_city": "Salt Lake City",
        "research_diseases": "chronic pain||addiction||opioid misuse",
        "research_fields": "neuroscience||clinical_research",
        "key_technologies": "EEG||Mindfulness-Oriented Recovery Enhancement (MORE)",
        "key_achievements": "Largest neuroscience study of mindfulness for addiction||MORE shown to reduce opioid misuse by 45%",
        "international_collaboration": "",
        "funding_sources": "government grant",
        "technology_application": "mindfulness-based therapy for chronic pain and opioid misuse"
    },
    {
        "institution_name": "St. Jude Children's Research Hospital",
        "institution_type": "public||university-affiliated",
        "parent_organization": "",
        "leadership": "James Downing||Tanja Gruber",
        "institution_country": "USA",
        "institution_city": "Memphis",
        "research_diseases": "acute lymphoblastic leukemia||childhood cancer||medulloblastoma||ependymoma||neuroblastoma||Ewing sarcoma||osteosarcoma",
        "research_fields": "oncology||genomics||clinical_research",
        "key_technologies": "targeted drug treatments||ultraprecision radiation||immunotherapy||genome sequencing",
        "key_achievements": "high remission rates in MLL-rearranged acute lymphoblastic leukemia||Pediatric Cancer Genome Project discoveries",
        "international_collaboration": "Washington University in St. Louis",
        "funding_sources": "philanthropy",
        "technology_application": "experimental treatment for acute lymphoblastic leukemia||genome sequencing for pediatric cancer patients"
    },
    {
        "institution_name": "Einstein||Montefiore Medical Center||The Children's Hospital at Montefiore",
        "institution_type": "university-affiliated||public",
        "parent_organization": "",
        "leadership": "Teresa P. DiLorenzo||Rubina A. Heptulla",
        "institution_country": "USA",
        "institution_city": "Bronx",
        "research_diseases": "Type 1 Diabetes",
        "research_fields": "immunology||microbiology||endocrinology||clinical_research",
        "key_technologies": "dendritic cell antigen presentation",
        "key_achievements": "discovery of HbA1c as a marker for diabetes",
        "international_collaboration": "TrialNet",
        "funding_sources": "philanthropy",
        "technology_application": "screening for type 1 diabetes risk using autoantibody testing"
    },
    {
        "institution_name": "Microbiome Research Centre||MRC",
        "institution_type": "university-affiliated",
        "parent_organization": "UNSW Sydney",
        "leadership": "Professor Emad El-Omar||Professor Michael Grimm||Professor Georgina Hold",
        "institution_country": "Australia",
        "institution_city": "Sydney",
        "research_diseases": "inflammatory bowel disease||gastrointestinal cancer||Helicobacter pylori infection",
        "research_fields": "microbiology||immunology||bioinformatics||clinical_research",
        "key_technologies": "bioinformatics algorithms||multi-omic technologies",
        "key_achievements": "Crohn__ and Colitis Australia scholarship",
        "international_collaboration": "Fulbright Scholarship||Harvard School of Public Health",
        "funding_sources": "",
        "technology_application": "IBD clinic that uses biologic therapy"
    }
]